67 research outputs found
Radiation recall dermatitis after oral cyclophosphamide
peer reviewedRadiation recall dermatitis is an inflammatory skin reaction occurring in a previously irradiated field following the delivery of a promoting agent. It has been described after a number of antineoplastic agents such as gemcitabine, taxanes, anthracyclines. We report the case of a 50-year-old man with metastatic prostate cancer who developed two consecutive radiation recall dermatitis episodes triggered by oral cyclophosphamide. They occurred 4 to 5 weeks after palliative radiotherapy on bone metastasis. Spontaneous resolution was observed within 6 weeks after discontinuation of cyclophosphamide and with local supportive care. To our knowledge this is the first reported case of radiation recall dermatitis after oral cyclophosphamide
Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study.
peer reviewedBACKGROUND: The spread of the COVID-19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. AIM: An analysis of cancer patients fears, and awareness of COVID-19 has been done in this study. METHODS AND RESULTS: We analyzed cancer patients' reactions to the pandemic and their perception of oncological care reorganization, through a 12-item survey, proposed at the peak of pandemic and 3 months later. Overall, 237 patients were included in the study. During the peak of pandemic 34.6% of patients were more worried about COVID-19 than cancer versus 26.4% in the post-acute phase (p = .013). Although 49.8% of patients in the acute phase and 42.3% in the post-acute phase considered their risk of death if infected ≥50%, and more than 70% of patients thought to be at higher risk of complications, the majority of them did not consider the possibility to stop or delay their treatment. Patients were more interested in following news about COVID-19 than cancer and they complied with all preventive measures in more than 90% of the cases. CONCLUSIONS: Although cancer patients worried about COVID-19 and evaluated the risk of complication or death due to COVID-19 as extremely high, they were still asking for the best oncological treatment
L'image du mois. Une image de "lâcher de ballons" à l'imagerie thoracique
peer reviewe
Early onset of head and neck squamous-cell carcinoma and fatal toxicity with concurrent chemoradiotherapy in a patient compound heterozygote for FANCA gene
[No abstract available
EXPLORATION ET TRAITEMENT D’UN CARCINOME EPIDERMOIDE GANGLIONNAIRE CERVICAL SANS PRIMITIF DECELE
peer reviewedA l’heure actuelle, le bilan à réaliser après décou
-
verte d’une adénopathie cervicale est bien codifié. Le PET-
scan, dans un premier temps controversé, s’affirme étude
après étude comme un élément essentiel. La stratégie de
traitement pratiquée dans la plupart des centres consiste en
un évidemment cervical suivi de radiothérapie portant sur
les muqueuses pharyngées ainsi que sur les relais ganglion
-
naires cervicaux bilatéraux avec éventuelle association à une
chimiothérapie. Celle-ci est ajoutée en fonction de facteurs
anatomo-pathologiques de mauvais pronostic, mais elle n’a
pas fait la preuve de sa supériorité. De multiples études de
phase II aboutissent d’ailleurs à des conclusions opposées. En
dehors de données issues d’études randomisées, le traitement
aujourd’hui se décide par analogie à ceux qui sont appliqués
lorsque le site primitif tumoral est identifié dans la sphère
ORL
- …